AC Immune (ACIU) Interest & Investment Income (2014 - 2026)
AC Immune's (ACIU) quarterly Interest & Investment Income came in at $291157.1 in Q1 2026, down 61.9% year-on-year from $764116.1 in Q1 2025, and up 132.82% on a QoQ basis from -$887079.4 in Q4 2025.
AC Immune (ACIU) Interest & Investment Income (2014 - 2026) Analysis & Trends
AC Immune (ACIU) has 12 years of Interest & Investment Income data on file, last reported at $291157.1 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 61.9% year-over-year to $291157.1 in Q1 2026; TTM through Mar 2026 was $414831.5, a 88.73% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 38.34% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $291157.1, up from -$887079.4 in the prior quarter.
- Over the last five years, Interest & Investment Income for ACIU reached as high as $1.1 million in Q3 2024 and fell as low as -$887079.4 in Q4 2025.
- Historically, Interest & Investment Income has averaged $310900.4 across 5 years, with a median of $291157.1 in 2026.
- Across the five-year window, Interest & Investment Income tumbled 263.25% in 2022 and soared 2732.86% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $60205.3 in 2022, then surged by 216.46% to $190522.9 in 2023, then jumped by 432.65% to $1.0 million in 2024, then tumbled by 187.41% to -$887079.4 in 2025, then surged by 132.82% to $291157.1 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $291157.1 in Q1 2026, -$887079.4 in Q4 2025, and $457540.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | 291,157.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 291,157.07 |
| Dec 31, 2025 | -887,079.38 |
| Sep 30, 2025 | 457,540.08 |
| Jun 30, 2025 | 553,213.72 |
| Mar 31, 2025 | 764,116.12 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 817,181.39 |
| Mar 31, 2024 | 720,634.18 |
| Dec 31, 2023 | 190,522.91 |
| Sep 30, 2023 | 322,663.48 |
| Jun 30, 2023 | 288,053.47 |
| Mar 31, 2023 | 225,962.98 |
| Dec 31, 2022 | 60,205.27 |
| Sep 30, 2022 | 11,390.02 |
| Jun 30, 2022 | -435,044.77 |
| Mar 31, 2022 | -193,822.70 |
| Dec 31, 2021 | 2.24 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 266,485.25 |